STD 07

Drug Profile

STD 07

Alternative Names: STD-007; STD07

Latest Information Update: 16 Sep 2015

Price : $50

At a glance

  • Originator SunTen Phytotech
  • Developer Lumosa Therapeutics
  • Class Anthraquinones
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Gastrointestinal disorders

Highest Development Phases

  • Discontinued Constipation; Inflammatory bowel diseases

Most Recent Events

  • 16 Sep 2015 Discontinued - Phase-I for Inflammatory bowel disease in Taiwan (PO)
  • 16 Sep 2015 Discontinued - Phase-I/II for Constipation in Taiwan (PO)
  • 11 Feb 2011 Phase I/II development is ongoing in Taiwan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top